GlassScriptPhysician profile
Piyush Aggarwal
NPI 1700070273
$8,893.39
in general payments reported to CMS, 2019-2025
26 companies · $33.33 in 2025
The $33.33 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,006 · 2020: $1,043 · 2021: $278 · 2022: $361 · 2023: $153 · 2024: $3,019 · 2025: $33.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,200 · Travel and Lodging: $622 · Food and Beverage: $383.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,200.00 |
| Travel and Lodging | $621.84 |
| Food and Beverage | $383.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,634.84 | 2019-2024 | |
| Medtronic USA, INC. | $1,363.46 | 2019 | |
| Axonics, INC. | $786.94 | 2022-2024 | Axonics, Bulkamid |
| Abbvie INC. | $198.13 | 2019-2022 | |
| Becton, Dickinson and Company | $170.61 | 2022 | |
| Conmed Corporation | $139.55 | 2022 | |
| Janssen Scientific Affairs, LLC | $98.87 | 2019 | |
| Coloplast Corp | $52.45 | 2023 | Sensura Mio |
| Stryker Corporation | $42.13 | 2021 | |
| Medtronic, INC. | $41.29 | 2023 | Eea |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $38.62 | 2019 | |
| Pfizer INC. | $37.42 | 2019 | |
| Davol INC. | $33.33 | 2025 | Phasix Mesh |
| Ethicon US, LLC | $32.75 | 2019-2021 | |
| Shionogi INC | $29.25 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $27.55 | 2023 | Simponi Aria, Simponi, Stelara |
| Gilead Sciences, INC. | $27.14 | 2021 | |
| Tesaro, INC. | $24.69 | 2019 | |
| Braintree Laboratories, INC. | $22.08 | 2021 | |
| Baxter Healthcare | $17.49 | 2021 | |
| Edwards Lifesciences Corporation | $17.28 | 2023 | Mitris Resilia Mitral Valve |
| Avanos Medical | $16.72 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.18 | 2019 | |
| Merck Sharp & Dohme LLC | $12.44 | 2019 | |
| Boston Scientific Corporation | $12.18 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Piyush Aggarwal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.